Glofitamab CD20-TCB bispecific antibody
Author:
Affiliation:
1. Clinical Haematology, Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia
2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1953016
Reference75 articles.
1. Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
2. How I manage patients with relapsed/refractory diffuse large B cell lymphoma
3. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
4. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
5. Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis and Activity of T-Cell Tumor-Directing MegaMolecules;Journal of the American Chemical Society;2024-08-21
2. Stepping forward: T-cell redirecting bispecific antibodies in cancer therapy;Acta Pharmaceutica Sinica B;2024-06
3. Bispecific and multispecific antibodies in oncology: opportunities and challenges;Nature Reviews Clinical Oncology;2024-05-31
4. A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-03-26
5. Structure and function of therapeutic antibodies approved by the US FDA in 2023;Antibody Therapeutics;2024-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3